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Summary





infectious agent responsible for the disease Asiatic





such as those encoding the cholera toxin (CT) and
toxin-coregulated pilus (TCP), are controlled by a
cascade of transcriptional activators. Ultimately, the





 virulence genes is the AraC/XylS family
member ToxT protein, the expression of which is acti-
vated by the ToxR and TcpP proteins. Previous stud-
ies have identified the DNA sites to which ToxT binds








 operon, encoding, among other products, the
major subunit of the TCP. These known ToxT binding
sites are seemingly dissimilar in sequence other than








 each has a pair of ToxT binding sites arranged
in a direct repeat orientation upstream of the core










footprinting experiments, we have identified the ToxT








 genes,  which  encode  components
of the accessory colonization factor required for














 in an inverted repeat orienta-
tion. Moreover, a mutational analysis of the ToxT bind-
ing sites indicates that both binding sites are required








. Using copper-phenanthroline footprinting to
assess the occupancy of ToxT on DNA having muta-
tions in one of these binding sites, we found that
protection by ToxT of the unaltered binding site was
not affected, whereas protection by ToxT of the
mutant binding site was significantly reduced in the
region of the mutations. The results of further foot-








10 bp insertions between the two ToxT
binding sites indicate that both binding sites are
occupied by ToxT regardless of their positions rela-
tive to each other. Based on these results, we propose













The severe diarrhoeal disease cholera is caused by the









 is usually acquired by ingestion of con-
taminated food or water (Finkelstein, 1973). The primary
factor required for cholera disease is the cholera toxin





and Holmgren, 1973; Gill, 1976). Cholera toxin enters the
intestinal epithelium by binding, with its five B subunits, to
ganglioside GM1, followed by transport of the one active





A subunit activates adenylate cyclase, resulting in a large
increase in cyclic AMP (cAMP) levels. This induces secre-
tion of fluid into the lumen of the intestine to produce the
voluminous watery diarrhoea (‘rice water stool’) that is













 (Waldor and Mekalanos,




requires the toxin-coregulated pilus (TCP), a type IV pilus




 operon, which is





., 1987; Peterson and Mekalanos, 1988).




 (Waldor and Mekal-





 chromosome within the vibrio patho-














Expression of CT and TCP is subject to control by a
























regulators. The direct activator of transcription of the
genes encoding both CT and TCP is ToxT, a 32 kDa cyto-













 from its own promoter is initiated by
the combined activity of two membrane-localized
transcriptional activators, ToxR and TcpP (Hase and




., 2000; Krukonis and
DiRita, 2003). These proteins, along with their protein














 is then induced by ToxT itself through









 gene is located
(Higgins and DiRita, 1994; Brown and Taylor, 1995; Yu





is also located within the VPI, is positively regulated by
the transcriptional activators AphA and AphB, and
negatively regulated by the cAMP receptor protein (CRP)
and PepA protein (Kovacikova and Skorupski, 1999;





2001). Also implicated in this cascade is HapR, whose
activity is controlled by the quorum-sensing system, and




















ToxT protein is a member of the AraC/XylS family of





family members have in common a conserved DNA bind-
ing and transcriptional activation domain of approximately





., 1997; Martin and Rosner, 2001;
Tobes and Ramos, 2002). Crystal structures that include
the conserved domain have been determined for two









., 2000). The crystal structures of MarA
and Rob bound to DNA suggest that the modes of DNA
binding utilized by these two proteins differ; the structure
of MarA bound to DNA indicates that both helix–turn–helix
motifs specifically interact with the major groove, whereas
the structure of Rob bound to DNA indicates that only
the more N-terminal helix–turn–helix interacts specifically
with the major groove. ToxT carries the 100-amino-acid
AraC/XylS domain as its C-terminal domain. However,
ToxT also has a 176-amino-acid N-terminal domain of
unknown function. Other members of the AraC/XylS fam-
ily having a second domain typically use this domain for





1997; Martin and Rosner, 2001; Tobes and Ramos, 2002).
Whether ToxT is monomeric, as are some AraC/XylS fam-
ily members, or forms dimers or multimers in solution, as
do other AraC/XylS family members, has not been deter-
mined. The stoichiometry of ToxT binding to DNA has also
not been determined.
Previous studies on ToxT function have focused prima-













 (Yu and DiRita, 2002). First, ToxT acts




. It does so by competing for




 with H-NS protein,
which has multiple binding sites located in this region and














presumably by interacting with RNA polymerase. In con-




 expression, H-NS has













, ToxT acts not as
an anti-repressor but only as a direct activator of transcrip-
tion. This is most probably through interaction between









-CTD) (Hulbert and Taylor, 2002; Yu
and DiRita, 2002).








core promoter elements were identified using both genetic
methods and DNase I footprinting experiments (Hulbert
and Taylor, 2002; Yu and DiRita, 2002). The sequences
of these ToxT binding sites are somewhat dissimilar from
each other, and a consensus sequence is not evident. The








ToxT binding sites are poly A or poly T tracts of five or
more contiguous A or T nucleotides on one strand of the









have three of these tracts. Mutational analyses of the ToxT




 using either a
genetic screen (Hulbert and Taylor, 2002) or a site-
directed approach (J.H. Withey and V.J. DiRita, in prepa-
ration) indicated that the promoter-proximal and promoter-





. Mutations in the central A/T tract had little to










 in a direct repeat orientation, with each
site containing one A/T tract.








 operons, ToxT also activates expression of at

























., 1991). All of these genes are located








, poly A or
poly T tracts are found upstream of each of these genes,
and these are the only obvious similarities in the DNA
sequences upstream of these genes, which presumably









transcribed genes that encode components of the acces-
sory colonization factor (ACF) (Peterson and Mekalanos,
1988). The exact role of the ACF in pathogenesis is








J. H. Withey and V. J. DiRita 
 



























 encodes a putative transmembrane protein (Harkey
 
et al., 1995). The roles, if any, of aldA and tagA in patho-
genesis are unknown. tcpI encodes a putative methyl-
accepting chemotaxis protein (Harkey et al., 1994). Again,
the role, if any, of tcpI in pathogenesis is unknown.
In the studies described in this report, we used a com-
bination of mutational analysis and copper-phenanthroline
footprinting experiments to identify sites located between
acfA and acfD that are required for ToxT binding and
transcriptional activation. These ToxT binding sites are
arranged in an inverted repeat orientation; this is in con-
trast to the previously described ToxT binding sites at tcpA
and ctx, which are in direct repeat orientations. However,
in similarity to ctx and tcpA, each of the acfA/acfD ToxT
binding sites contains one A/T tract. Occupancy of both
ToxT binding sites is required for transcription of both acfA
and acfD. Mutation of one of the two binding sites does
not significantly affect occupancy by ToxT of the unaltered
binding site. Furthermore, both sites remain occupied by
ToxT even when the spacing between the two binding
sites is altered by the insertion of 5 or 10 base pairs (bp).
Based on these results and previous work on other
members of the AraC/XylS family, we propose that one
ToxT monomer binds independently to each of the two
binding sites between acfA and acfD, and that both ToxT
monomers are required to make contacts with the RNA
polymerase a-CTDs to activate transcription of acfA and
acfD.
Results
Identification of the minimal acfA promoter region
There is a near consensus -10 sequence (TATAAT) found
upstream of both genes, the spacing of which is in good
agreement with where primer extension experiments sug-
gested each transcript initiates (data not shown). How-
ever, both genes have a degenerate putative -35
sequence at the appropriate position relative to the -10
element (Fig. 1). To determine the length of DNA
upstream of the core promoter elements of acfA that is
required for ToxT-directed transcription, we constructed
nested acfA::lacZ fusions in which the 5¢ end point of DNA
upstream from the transcription start site for acfA varies
from -146 to -66 (Fig. 2). These fusions were constructed
in plasmid pTL61T, which has a promoterless lacZ gene
downstream of a multiple cloning site (Linn and St Pierre,
1990). The effect of ToxT on expression of the fusions was
determined by measuring b-galactosidase activity in wild-
type and toxT mutant V. cholerae strains (O395 and VJ740
respectively; Champion et al., 1997).
ToxT-dependent acfA–lacZ expression was observed
with fragments harbouring DNA upstream of and including
residue -88 (Figs 2 and 3). The next deletion in the series,
acfA4, with its end point at -66, was inactive irrespective
of the presence of ToxT. Deletion to -88 (acfA3) appar-
ently removes a site that inhibits ToxT from activating the
acfA promoter, as the acfA3 construct expressed about
two and a half times more ToxT-dependent b-galactosi-
dase activity than either of the other two fusions with end
points upstream of -88 (acfA1 and acfA2). This was not
accompanied by an elevated basal level of transcription
(i.e. in the absence of ToxT) and thus the behaviour of this
promoter is distinct from that previously observed with the
ctx promoter (Yu and DiRita, 2002). In that analysis, dele-
tion of specific upstream sequences led to increased
basal transcription and a concomitantly increased level of
ToxT-activated transcription (Yu and DiRita, 2002). This
was attributed to the effects of the nucleoid-like protein H-
NS, which is known to antagonize ToxT-dependent activa-
tion of the ctx promoter (Nye et al., 2000; Yu and DiRita,
Fig. 1. Sequence of the acfA–acfD intergenic region. Both strands of 
the DNA are shown, with landmarks for acfD on the top strand and 
landmarks for acfA on the bottom strand. The start sites of transcrip-
tion are shown by an arrow on the top strand for acfD and by an arrow 
on the bottom strand for acfA. The putative core -35 and -10 ele-
ments for each promoter are indicated by boxes. The region of overlap 
of the minimal ToxT-directed constructs for acfA and acfD is indicated 
by a thick line between the top and bottom strand sequences. The 
end points of the acfD2 and acfA4 constructs are also shown. The 
positions of mutations are indicated by arrows pointing from the 
mutant designation to the mutated base pairs. Each of the mutations 
changes an A/T base pair to a G/C base pair. As indicated, the 
acfD11 and acfA16 constructs have identical mutations at the same 
two base pairs, as do the acfD12 and acfA15, acfD15 and acfA17 
and acfD13 and acfA13 mutations. The position of the insertions in 
the acfD21 and acfD22 constructs is indicated by the triangles above 
and below the sequence. The +5 bp DNA sequence inserted in 
acfD21 is GATCG on the top strand and the +10 bp DNA sequence 
inserted in acfD22 is GATCGATCGA on the top strand.
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2002). These results indicate that DNA sequence infor-
mation required for ToxT-directed transcription of acfA
resides within 88 nucleotides upstream of transcription
initiation. The promoter is also subject to some measure
of inhibition through sequence information between -115
and -88 (Fig. 3).
Mutational analysis of the acfA promoter region
The most significant similarities in sequence upstream of
all the known ToxT-controlled genes are the presence of
tracts of A or T nucleotides, so these tracts upstream of
acfA were targeted for mutagenesis to assess their role
in ToxT-directed transcription of acfA. Site-directed muta-
tions were created in derivatives of the minimal ToxT-
directed acfA::lacZ fusion, acfA3, which ends at position
-88 (Fig. 1). The most dramatic effects were produced by
changing the base pairs at -74 and -75 from A/T to G/C
(acfA13) and by changing the base pairs at -54 and -56
from A/T to G/C (acfA16) (Fig. 3). In each case, the fusion
was expressed to the same, low level in both the wild-type
and DtoxT backgrounds, suggesting that the base pairs at
-74/-75 and -54/-56 are required for ToxT-directed tran-
scription of acfA.
Two other mutations we introduced affected the basal
(ToxT-independent) expression of the fusion alleles
slightly, but we can nevertheless draw some conclusions
about the requirements for the altered residues in ToxT-
dependent activation. Allele acfA17 exhibited a slightly
higher baseline level of activation that was stimulated
when ToxT was present (Fig. 3). The absolute level of
ToxT-dependent expression was lower than the wild-type
acfA4 allele, and thus we conclude that the residues at -
69 and -67 are important, but not essential, for ToxT to
activate. The elevated activity in the absence of ToxT was
not explored further. In acfA15, fusion activity in the toxT
mutant background was somewhat lower than we saw
with acfA3 but, again, this allele was significantly stimu-
lated in the presence of ToxT (Fig. 3). Activation of acfA15
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Fig. 2. Map of the nested lacZ fusion con-
structs. The black line at the top of the figure 
represents the entire acfA–acfD intergenic 
region. Arrows indicate transcriptional start 
sites. The fusion construct names are listed on 
the left side, and the size of the construct is 
represented by the length of the black line. The 
numbers on either side of the black line indicate 
the length of DNA present in the construct rel-
ative to the transcriptional start site. The open 
box indicates the region of overlap between the 
minimal acfA::lacZ and acfD::lacZ fusions from 
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Fig. 3. Results of b-galactosidase assays on 
strains carrying acfA::lacZ fusions. The results 
of experiments performed with V. cholerae 
strains having wild-type ToxT (O395) are repre-
sented as grey bars, and the results of experi-
ments performed with V. cholerae strains 
having a ToxT deletion (VJ740) are represented 
as white bars. ‘Allele’ indicates which acfA::lacZ 
fusion construct was used in the experiment, 
except for pTL61T, in which the empty vector 
was present in the indicated strains; ‘5¢ end 
point’ indicates the length of DNA upstream of 
the transcriptional start site that is present in 
the construct; and ‘toxT/DtoxT’ indicates the fold 
difference between the mean b-galactosidase 
values for that construct measured in O395 and 
measured in VJ740. b-Galactosidase assays 
were performed in each strain a minimum of 
three times, and the values shown are the 
mean ± standard deviation.
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exhibited ToxT-directed transcription, and thus, as with
acfA17 we conclude that the A/T residues mutated in this
allele (at -59 and -61) are important for, but not absolutely
critical to, ToxT-dependent expression.
Finally, changing the base pairs at -82 and -83 from A/
T to G/C, to create acfA14, had a minimal effect, if any,
on transcription. As expected, mutations to A or T tracts
located upstream of -88 had no effect on ToxT-directed
transcription of acfA (data not shown).
Identification of the minimal acfD promoter region
We used a method similar to that described above for acfA
to determine the length of DNA upstream of the core
promoter elements of acfD that is required for ToxT-
directed transcription. Nested lacZ fusions were con-
structed in pTL61T, and b-galactosidase levels were
assayed in strains carrying these fusions and having
either wild-type toxT or a deletion in toxT. This series
extended from -139 bp upstream to -66 bp upstream of
the transcription start site (Fig. 2). The first observation to
note is that the ratio of ToxT-dependent to basal expres-
sion of acfD is much greater than that of acfA, reflecting
primarily a lower basal promoter activity for acfD (Fig. 4).
The wild-type toxT strain carrying acfD1 produced 24-
fold more b-galactosidase activity than the DtoxT strain
carrying acfD1 (Fig. 4). Deletion of the DNA sequence
between -139 and -87 (acfD2) had no effect on ToxT-
directed transcription of acfD. However, truncation of the
DNA sequence to -66 (acfD3) abrogated ToxT-directed
transcription of acfD (Fig. 4). Therefore, the sequence
between -87 and -66 relative to the start of acfD tran-
scription must contain determinants for ToxT-directed tran-
scription of acfD (Fig. 1), and the region from -87 to +12
is sufficient for ToxT-directed transcription of acfD. The
minimal acfA4::lacZ and acfD2::lacZ fusion constructs
that exhibit ToxT-directed transcription of these genes
overlap by 52 bp (Figs 1 and 2), suggesting that a single
ToxT control region may exist between acfA and acfD.
Mutational analysis of the acfD promoter region
The A and T-rich sequences upstream of acfD were also
targeted for mutation to determine their importance to
ToxT-directed transcription of acfD. Site-directed muta-
tions were created in derivatives of the minimal ToxT-
directed acfD::lacZ fusion, acfD2, which ends at position
-87 (Fig. 1) and is activated over 30-fold by ToxT. Muta-
tions having the strongest negative effects on ToxT-
directed transcription of acfD2 were A/T to G/C alterations
at -70/-68 (acfD11), -50/-49 (acfD13) and -74/-72
(acfD14). All of these mutant alleles expressed ToxT-
dependent b-galactosidase at levels barely above back-
ground, and had toxT/DtoxT ratios over 15 times lower
than the wild-type allele. Thus, it is clear that these resi-
dues are essential for ToxT-dependent activation of acfD.
The other two mutant alleles we investigated in this
series could still be activated by ToxT, but the level of
activation was much lower than the acfD2 allele. These
are acfD12, with A/T to G/C changes at -65 and -63, and
acfD15, with these changes at -57 and -55. acfD15 in
particular was still activated over eightfold by ToxT, but this
level of activation is significantly lower than the 33-fold
activation seen with acfD2. We conclude that these four
residues are required for maximum ToxT-dependent
expression, but that even without them ToxT remains
capable of some degree of activation.
The mutations with the largest negative effect on ToxT-
directed acfD transcription, acfD11 and acfD13, are iden-
tical mutations to those in alleles acfA16 and acfA13,
Fig. 4. Results of b-galactosidase assays on strains carrying acfD::lacZ fusions. The results of experiments performed with V. cholerae strains 
having wild-type ToxT (O395) are represented as grey bars, and the results of experiments performed with V. cholerae strains having a toxT 
deletion (VJ740) are represented as white bars. ‘Allele’ indicates which acfD::lacZ fusion construct was used in the experiment; ‘5¢ end point’ 
indicates the length of DNA upstream of the transcriptional start site that is present in the construct; and ‘toxT/DtoxT’ indicates the fold difference 
between the mean b-galactosidase values for that construct measured in O395 and measured in VJ740. b-Galactosidase assays were performed 
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respectively (Fig. 1), which were the most severely
affected for ToxT-directed transcription (Figs 3 and 4). This
suggests that ToxT activates transcription of both genes
from the same central control region.
Identification of the ToxT binding sites between acfA and 
acfD by copper-phenanthroline footprinting
The genetic experiments described above allowed us to
determine regions between acfA and acfD that are
required for ToxT-directed transcription. Electrophoretic
mobility shift analysis (EMSA) confirmed that purified
ToxT binds specifically to the acfA–acfD intergenic DNA
(data not shown) but did not provide any information
regarding the stoichiometry of binding. This is because,
as we have previously shown, ToxT–DNA complexes
enter the gel poorly, and we are not able to resolve distinct
complexes of bound monomers versus bound dimers (e.g.
Yu and DiRita, 2002).
To more precisely identify the DNA sequence bound by
ToxT we used DNA footprinting. Standard DNase I foot-
printing gave unclear results (data not shown), presum-
ably because the DNA sequence between acfA and acfD
has abundant A and T nucleotides, including numerous
poly A tracts, and these are poorly cleaved by DNase I
due to narrowing of the minor groove (Nelson et al., 1987;
Urbach and Dervan, 2001). Instead, we used the copper-
phenanthroline footprinting technique, in which chemical
digestion of the DNA was performed after electrophoretic
separation of the H6-ToxT/DNA complexes and free DNA.
The chemically digested protein/DNA complexes and free
DNA were then eluted from the EMSA gel and run side
by side on a sequencing gel beside a sequencing ladder
to assess where H6-ToxT had prevented chemical cleav-
age of the DNA, indicating a region of specific binding. As
shown in Fig. 5, we observed a single region of protection
between acfA and acfD conferred by H6-ToxT, bracketed
by hypersensitive sites at positions -49 and -77 relative
to the acfA transcription start site or -47 and -75 relative
to the acfD transcription start site. This protection is in the
same DNA region we identified as being required for ToxT-
directed transcription of both acfA and acfD in the lacZ
fusion experiments described above. More specifically,
the 5¢ end points of the acfA4::lacZ and acfD3::lacZ fusion
constructs, which do not exhibit ToxT-directed transcrip-
tion, are within the DNA sequence protected by ToxT in
these experiments, indicating that the failure of ToxT to
activate transcription of these constructs results from dis-
ruption of the ToxT/DNA binding region. The strongest
protection was seen in the area around the two A/T tracts,
mutation of which completely abrogated activation of tran-
scription by ToxT. The areas between the A/T tracts
showed less complete protection (Fig. 5).
The DNA sequence between acfA and acfD that is
protected from chemical cleavage by ToxT contains a
degenerate inverted repeat sequence, with 9 out of 13
nucleotides in each side of the repeat having the same
identity (asterisks in Fig. 6A). The 5¢ portion of each side
of the repeat sequence contains a T tract, and the 3¢
portion is A/T rich. Mutations to the 5¢ T tract of either side
of the repeat sequence abrogated ToxT-dependent tran-
scription of both genes (acfA13, acfA16, acfD11, acfD13).
Comparison of these ToxT binding sites to the previously
Fig. 5. Copper-phenanthroline footprinting of H6-ToxT in the acfA–
acfD intergenic region. The lane having DNA cleaved by copper-
phenanthroline in the absence of H6-ToxT is indicated by the ‘–’ 
symbol and the lane having H6-ToxT/DNA complexes cleaved by 
copper-phenanthroline is indicated by the ‘+’ symbol. The numbers to 
the right of the autoradiograph indicate the distances upstream of the 
transcriptional start sites of acfA and acfD, with numbers applying to 
acfD in standard type and numbers applying to acfA underlined. The 
-35 core promoter elements are represented by empty boxes. 
The vertical line indicates the region of protection by H6-ToxT. The 
sequence of the inverted repeat region depicted in Fig. 6A is shown 
beside the sequencing lanes. The locations of mutations that strongly 
affect ToxT-directed transcription of acfA and acfD are shown by 
arrows extending from the mutant designation.
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identified ToxT binding regions upstream of ctx and tcpA
shows conservation of the T tract in the 5¢ half of the
binding site (Fig. 6B). The 3¢ portion of the binding sites
are A/T rich, but have no specific sequence conservation.
The most significant difference between the acfA and acfD
ToxT binding sites and the ctx and tcpA ToxT binding sites
is that the former are arranged in an inverted repeat ori-
entation, whereas the latter are arranged in a direct repeat
orientation (J.H. Withey and V.J. DiRita, in preparation).
Mutations that prevent ToxT-directed transcription 
reduce specific binding of ToxT only to the mutated 
DNA binding site
The results described above suggest that ToxT binds to
two DNA sites in an inverted repeat configuration between
acfA and acfD, and that occupancy of both of these DNA
sites is required for ToxT-directed transcription of both
acfA and acfD. We next asked how the occupancy of the
putative ToxT binding sites is changed when one of the
sites has mutations that prevent ToxT from activating tran-
scription. EMSA experiments indicated that ToxT still
binds specifically to the mutated DNA sites (data not
shown). To further address this question, we performed
copper-phenanthroline footprinting experiments on com-
plexes of H6-ToxT and DNA from mutants that are defec-
tive for ToxT-directed transcription of acfA and/or acfD.
These mutants have alterations in either one or the other
of the two putative ToxT DNA sites located between acfA
and acfD. DNA from the acfA16 construct, which has
mutations in the T tract of the acfA-proximal ToxT binding
site (and which has mutations identical to those in the
acfD11 construct; Fig. 1), shows reduced protection by
ToxT from chemical cleavage in the mutated binding site
surrounding the location of the mutations (arrows in
Fig. 7). However, the other ToxT binding site shows no
apparent reduction in protection by ToxT. Likewise, DNA
from the acfA17 construct, which has mutations in the 3¢
A/T-rich portion of the acfA-distal ToxT binding site (and
which has mutations identical to those in the acfD15 con-
struct; Fig. 1), shows reduced protection from chemical
cleavage by ToxT in the mutant binding site (Fig. 7). The
unaltered ToxT binding site, however, shows no apparent
reduction in protection by ToxT. This mutant is particularly
notable because it reduces ToxT-directed transcription of
acfA (acfA17) but has little effect on ToxT-directed tran-
scription of acfD (acfD15). These results strongly suggest
that ToxT has two DNA binding sites between acfA and
acfD.
Insertions between the two ToxT binding sites do not 
abrogate ToxT binding to either site
The above results indicating that mutations to one ToxT
binding site do not affect protection by ToxT of the unal-
tered binding site raise the question of whether ToxT binds
independently to the two sites between acfA and acfD.
This question is made more compelling by our observa-
tions that ToxT uses a variety of binding site configurations
to activate transcription of different genes. For acfA and
acfD, as described above, and for tagA (J.H. Withey and
V.J. DiRita, in preparation), ToxT binds to two sites in
inverted repeat configurations. For ctx and tcpA, ToxT
binds to two sites in direct repeat configurations (J.H.
Withey and V.J. DiRita, in preparation). And for aldA, ToxT
binds to a single site (J.H. Withey and V.J. DiRita, in
preparation).
To address the question of whether ToxT binds inde-
pendently to its two sites between acfA and acfD, we
created derivatives of acfD2 having insertions of 5 bp or
10 bp between the two ToxT binding sites, creating the
acfD21 and acfD22 constructs, respectively (Fig. 1), and
performed copper-phenanthroline footprinting with H6-
ToxT on DNA amplified from these templates. We would
predict that footprinting to one or both of the ToxT sites
would be lost in the presence of a 5 bp insertion between
the sites if interactions between the ToxT molecules
bound to the two sites are required for binding. Because
these constructs are derivatives of acfD2, they show foot-
prints on the opposite DNA strand from those presented
earlier in this report using derivatives of acfA3 (Figs 5 and
7).
Fig. 6. A. Sequence of the inverted repeat between acfA and acfD. 
The nucleotides that are identical in the two binding sites are indi-
cated by asterisks above or below the sequence. Arrows represent 
the length and orientation of the putative binding sites.
B. Comparison of the acfA/acfD ToxT binding sites to the ToxT binding 
sites previously identified upstream of tcpA and ctx. ‘Spacing’ indi-
cates the distance between the two ToxT binding sites. ‘Promoter 
proximity’ indicates the promoter-proximal end of the nearest ToxT 
binding site relative to the start site of transcription. The consensus 
sequence is designated based on at least five out of the six binding 
sites having the indicated nucleotide at the indicated position. W 
signifies that the nucleotide can be either A or T.
A
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         Gene:            Sequence:                Repeat:           Spacing:        proximity: 
Inverted              2bp            –51/–46 
Direct                 7bp               –45 





acfD –75 –46  acfD
acfA –49 –78 acfA
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Clear protection was conferred by H6-ToxT in the area
of the binding sites previously identified using acfA3 deriv-
atives (Fig. 8, left). However, the hypersensitive sites pro-
duced by H6-ToxT in footprints on acfA3 and derivatives
(Figs 5 and 7) were not observed in footprints on acfD2
and derivatives. The 3¢ end of the acfD-proximal binding
site was also protected to a larger degree by H6-ToxT in
acfD2 and derivatives than in acfA3 and derivatives. The
regions of DNA exhibiting H6-ToxT-mediated protection
were otherwise identical in footprints of both strands.
Clear protection was also conferred by H6-ToxT to
acfD21 DNA, which has 5 bp inserted between the two
binding sites (Fig. 8, middle). Significantly, both binding
sites were protected by H6-ToxT, despite the fact that
these sites have been rotated approximately one half turn
of the DNA helix relative to their wild-type spacing. This
strongly suggests that the ToxT molecules bound to the
two binding sites are not interacting with each other.
Finally, protection was also conferred by H6-ToxT to
acfD22 DNA, which has 10 bp inserted between the two
binding sites (Fig. 8, right). To assess the effects of inser-
tions between the binding sites on transcriptional activa-
tion by ToxT, b-galactosidase assays were performed on
acfD21::lacZ and acfD22::lacZ fusions. Neither of these
constructs was able to support ToxT-directed transcription
(Fig. 9). This finding suggests that, although both of the
ToxT binding sites are occupied in both the acfA21 and
acfA22 constructs, this occupancy is not sufficient to allow
ToxT to activate transcription. Therefore, the spacing of
the binding sites relative to the promoter is an important
factor in ToxT-directed transcription.
Discussion
The experiments described in this report were designed
to determine the DNA sequence requirements for ToxT-
directed transcription of acfA and acfD, genes that have
poorly understood roles in the pathogenesis of V. chol-
erae, but were previously shown to be part of the ToxR
regulon (Peterson and Mekalanos, 1988; Parsot and
Mekalanos, 1992). Using nested lacZ fusions, we identi-
fied the minimal DNA sequences upstream of both acfA
and acfD required for ToxT-directed transcription of the
respective genes. The minimal ToxT-directed DNA con-
structs, acfA3 and acfD2, overlap by 52 bp (Figs 1 and 2).
This overlap of the DNA sequences required for ToxT-
directed transcription of acfA and acfD suggests that there
may be a single control region between the two genes
utilized by ToxT to activate transcription of both genes.
Mutational analyses of the minimal ToxT-directed DNA
constructs for acfA and acfD identified some of the spe-
cific sequence requirements for ToxT-directed transcrip-
tion of these genes. Examination of the DNA sequences
upstream of all the genes known to be within the ToxT
G A T C     –     +     –     +     –     +     G A T C 

























































Fig. 7. Copper-phenanthroline footprinting of 
H6-ToxT on acfA mutants defective in ToxT-
directed transcription. The lanes having DNA 
cleaved by copper-phenanthroline in the 
absence of H6-ToxT are indicated by the ‘–’ 
symbol and the lanes having H6-ToxT/DNA 
complexes cleaved by copper-phenanthroline 
are indicated by the ‘+’ symbol. The template 
construct from which the labelled DNA visible 
in the gel was amplified by PCR is shown above 
each pair of lanes. The sequence of the top 
strand of the inverted repeats depicted in 
Fig. 6A is indicated beside the sequencing 
lanes. The long arrows represent the putative 
ToxT binding sites. The black dots beside the 
free DNA lanes indicate where mutations are 
located. The short arrows denote nucleotides at 
which protection by H6-ToxT is decreased in the 
mutated binding sites relative to the wild-type 
binding sites.
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regulon yields no obvious consensus DNA binding
sequence. However, tracts of A and T nucleotides are
evident upstream of the core promoter elements of each
gene. The results of our mutational analyses of some of
the A and T-rich sequences between acfA and acfD deter-
mined some of the DNA sequence that is specifically
required for ToxT-directed transcription of these two
genes. Identical mutations in separate acfA::lacZ and
acfD::lacZ fusions had similar effects on b-galactosidase
expression from both fusions. For example, the acfA16
and acfD11 constructs have A/T to G/C changes to two
base pairs at the same positions (Fig. 1). Comparison of
b-galactosidase production in strains carrying the
acfA16::lacZ and acfD11::lacZ mutant constructs indi-
cates little to no ToxT-dependent transcription from the
mutant constructs, strongly suggesting that the base
pairs targeted for mutation are required for ToxT-directed
transcription of both acfA and acfD. Similarly, the
acfA13::lacZ and acfD13::lacZ constructs, which have
identical mutations, both allowed no ToxT-directed tran-
Fig. 8. Copper-phenanthroline footprinting of H6-ToxT on acfD constructs having insertions between the two ToxT binding sites. The lanes having 
DNA cleaved by copper-phenanthroline in the absence of H6-ToxT are indicated by the ‘–’ symbol and the lanes having H6-ToxT/DNA complexes 
cleaved by copper-phenanthroline are indicated by the ‘+’ symbol. The template construct from which the labelled DNA visible in the gel was 
amplified by PCR is shown above each pair of lanes. The long arrows represent the putative ToxT binding sites. The brackets beside the bound 
DNA lanes indicate where insertions between the binding sites are located.
acfD2 acfD21 acfD22





Fig. 9. Results of b-galactosidase assays on strains carrying 
acfD::lacZ fusions with +5 bp or +10 bp insertions between the ToxT 
binding sites. The results of experiments performed with V. cholerae 
strains having wild-type ToxT (O395) are represented as grey bars, 
and the results of experiments performed with V. cholerae strains 
having a ToxT deletion (VJ740) are represented as white bars. ‘Allele’ 
indicates which acfD::lacZ fusion construct was used in the experi-
ment and ‘toxT/DtoxT’ indicates the fold difference between the mean 
b-galactosidase values for that construct measured in O395 and 
measured in VJ740. b-Galactosidase assays were performed in each 
strain a minimum of three times, and the values shown are the 
mean ± standard deviation.
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scription. Constructs carrying the identical acfA15 and
acfD12 mutations both exhibited reduced, but still signifi-
cant, levels of activation by ToxT. Again, these results
strongly suggest that ToxT is acting at a single location
between acfA and acfD to activate transcription of both
genes.
The only mutations that caused significant differences
in the degrees of activation by ToxT were the identical
acfA17/acfD15 mutations. The acfA17::lacZ construct
produced only 2.2-fold higher levels of b-galactosidase in
the wild-type toxT strain than in the DtoxT strain, whereas
the acfD15::lacZ construct produced 8.9-fold higher levels
of b-galactosidase in the wild-type toxT strain than in the
DtoxT strain. The acfA17::lacZ construct did have a con-
siderably higher basal level of transcription than the other
acfA::lacZ constructs, which may or may not have any
bearing on this comparison. If the b-galactosidase levels
of these mutants in the presence of ToxT are compared
with the b-galactosidase levels in the wild-type con-
structs, as the relative percentage of gene expression,
the differences are less dramatic. Using this analysis, the
acfA17 construct had 44% relative gene expression, and
the acfD15 construct had 32% relative gene expression,
suggesting that the identical mutations have similar
effects on expression of both acfA and acfD. However, it
is possible that the base pairs that are mutated in these
constructs have different roles in activation of acfA and
acfD.
Copper-phenanthroline footprinting studies confirmed
that ToxT binds to a single location between acfA and
acfD. In these studies, a 28 bp segment of DNA at a
central location between acfA and acfD was strongly pro-
tected by ToxT, with complete protection seen in the
regions of the A/T tracts that are critical for ToxT-directed
transcription of both acfA and acfD. The overall region of
protection is consistent with our results from the lacZ
fusion experiments. The 5¢ end points of the acfA4 and
acfD3 constructs, from which ToxT is unable to activate
transcription, are within the region protected by ToxT in
the footprinting experiments. The obvious explanation for
this is that ToxT cannot activate transcription from a con-
struct having an incomplete set of DNA binding sites. The
5¢ end points of the minimal acfA3 and acfD2 constructs,
from which ToxT is able to activate transcription, are well
beyond the region protected by ToxT in the footprinting
experiments, as would be expected.
Examination of the DNA sequence that shows protec-
tion by ToxT in the footprinting experiments and is
required for ToxT-directed transcription of acfA and acfD
suggests that ToxT binds to two binding sites oriented as
an inverted repeat between the two genes (Fig. 6A). This
is unexpected considering that the previously identified
ToxT binding sites upstream of ctx and tcpA are most
probably oriented as direct repeats (J.H. Withey and V.J.
DiRita, in preparation). Moreover, as described above,
mutations in either of the putative ToxT binding sites
between acfA and acfD, and particularly in the A/T tracts,
have similar effects on transcription of both genes. We
believe that the 13 bp length of the putative ToxT binding
sites is consistent with each of these sites being bound
by a single ToxT monomer, based on the lengths of DNA
binding sites identified for other proteins in the AraC/XylS
family. For example, the related monomeric MarA, SoxS
and Rob proteins from Escherichia coli all bind to a
degenerate 19 bp DNA sequence (Martin et al., 1999;
Griffith and Wolf, 2001), and the dimeric RhaS and AraC
proteins each bind to a pair of 17 bp binding sites (Egan
and Schleif, 1994; Schleif, 2000). The dimeric AdpA pro-
tein from Streptomyces griseus binds to a pair of 10 bp
binding sites (Yamazaki et al., 2004). AraC/XylS family
proteins have a pair of helix–turn–helix motifs within their
DNA binding domains, and thus have the capability to
bind to two consecutive major grooves per protein mono-
mer. The lengths of the DNA sequences that are pro-
tected by ToxT in footprinting experiments both shown in
this report for the acfA–acfD promoter regions and
shown previously for the tcpA and ctx promoter regions
(Yu and DiRita, 2002) are most probably too large to be
occupied by a single ToxT monomer. The observation
that there are two conserved A/T tracts found upstream
of acfA, acfD and tcpA (J.H. Withey and V.J. DiRita, in
preparation), both of which are required for activation of
these genes by ToxT, and the observation that these
tracts are in a direct repeat orientation upstream of tcpA
and an inverted repeat orientation upstream of acfA and
acfD, also make the occupancy of this region by a single
ToxT monomer unlikely. Therefore, we propose that one
ToxT monomer binds to each of the two binding sites.
This idea is further supported by our observation that
only a single ToxT binding site is used by ToxT for activa-
tion of transcription of aldA (J.H. Withey and V.J. DiRita,
in preparation).
Further copper-phenanthroline footprinting studies that
assessed the occupancy of the two putative ToxT DNA
binding sites when one site carries mutations showed
reductions in the protection conferred by ToxT in the
region of the mutations. Footprinting experiments using
DNA from the acfA16 (acfD11) construct, which has a
pair of mutations that abrogates ToxT-directed transcrip-
tion of acfA, showed reduced protection by ToxT when
compared with the protection conferred by ToxT to DNA
from the wild-type acfA3 construct (Fig. 7). However, this
reduced protection by ToxT was only evident in the area
of the mutations; the unaltered binding site showed no
obvious reduction in protection by ToxT. Similarly, experi-
ments using DNA from the acfA17 (acfD15) construct,
which has a pair of mutations in the 3¢ portion of the other
putative ToxT binding site that reduces ToxT-directed tran-
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scription of acfA and acfD showed reduced protection by
ToxT in the region of the mutations. Again, the unaltered
binding site showed no obvious reduction in protection by
ToxT. This loss of protection is consistent with the idea
that occupancy of both binding sites by ToxT, or at least
of the regions of the binding sites containing the con-
served A/T tracts, is required for activation of transcription
by ToxT.
The finding that mutations to one ToxT binding site
affect occupancy by ToxT of that site but not occupancy
of the unaltered site, together with our observations that
ToxT uses a variety of binding site configurations, includ-
ing inverted repeats, direct repeats and a single binding
site, to activate transcription of different genes, raised the
question of whether interactions between bound ToxT
molecules are required for transcriptional activation. If
ToxT is indeed able to bind to pairs of DNA sites having
both direct and inverted repeat orientations, as we pro-
pose, the protein must be remarkably flexible to form or
maintain protein–protein interactions between ToxT mono-
mers in these different orientations. To address this ques-
tion we altered the spacing between the two acfA/acfD
ToxT binding sites by +5 bp and +10 bp and asked
whether ToxT would footprint the altered DNA. If ToxT
requires interactions between the monomers bound at
both sites, or binds to DNA as a dimer, rotating the binding
sites one half turn of the helix relative to each other should
disrupt any interactions between ToxT molecules and the
footprinting of one or both ToxT sites should be affected.
Our results strongly suggest that ToxT is able to footprint
both binding sites regardless of their positions relative to
each other. Therefore, we propose that ToxT binds as
independent monomers to the two sites between acfA and
acfD.
The consensus DNA sequence for ToxT binding that we
have proposed in this work has remarkably little character,
other than the presence of a T tract at the 5¢ end of the
site and preference for A/T-rich sequence at the 3¢ end of
the site. This degeneracy is not unusual for AraC/XylS
family protein DNA binding sites (Martin et al., 1999; Tho-
mas and Collins, 1999; Ibarra et al., 2003). Studies that
have identified the ToxT binding sites upstream of several
other genes upon which ToxT acts (J.H. Withey and V.J.
DiRita, in preparation) are consistent with the consensus
DNA sequence described here. Clearly there must be
other contextual cues for ToxT to recognize appropriate
binding sites, for a search of only the VPI using this con-
sensus sequence generates dozens of potential ToxT
sites, the vast majority of which are not utilized. We pro-
pose that the additional contextual information is mediated
by interactions between ToxT and RNA polymerase. This
may occur by a mechanism known as DNA scanning or
pre-recruitment that has been proposed for other AraC
family members having degenerate DNA binding sites
(Griffith et al., 2002; Martin et al., 2002). According to this
model, interaction between the activator protein and RNA
polymerase occurs before DNA binding. The extra binding
specificity conferred by the RNA polymerase/activator
complex permits identification of the appropriate binding
sites for that particular activator. In the absence of an
adjacent promoter, ToxT would not maintain occupancy of
its binding site, and would instead diffuse away with RNA
polymerase in search of an appropriate binding site. Pre-
vious studies using the tcpA promoter have shown that
ToxT most probably interacts with the a-CTD of RNA
polymerase (Hulbert and Taylor, 2002; Yu and DiRita,
2002). The spacing of ToxT binding sites described here,
relative to the core promoter elements, would also be
consistent with ToxT interacting with a-CTD of RNA poly-
merase as at a class I promoter. Another possibility, pro-
vided that ToxT monomers bound to different DNA sites
interact with each other, is that only DNA sites with the
appropriate spacing(s) and/or orientation(s) can maintain
occupancy by ToxT.
Regulation of transcription from divergent promoters by
centrally located proteins is quite common in bacteria
(Raibaud et al., 1989; Marques et al., 1998; Rhee et al.,
1999; Thomas and Collins, 1999; Browning et al., 2002;
Recchi et al., 2003). One particularly relevant example is
the Mycobacterium tuberculosis Rv1395 activator protein
(Recchi et al., 2003), which is also an AraC/XylS family
member, although the existence of multiple promoters for
both of the divergent genes it regulates, Rv1394c and
Rv1395, makes that example considerably more compli-
cated than what we observed for acfA and acfD, each of
which has a single promoter. Another AraC family mem-
ber, UreR, activates transcription of the divergent ureD
and ureR genes (D’Orazio et al., 1996; Thomas and Col-
lins, 1999). However, control of these genes is mediated
from independent UreR binding sites, so it is unlike what
we observed for acfA and acfD, which share a pair of ToxT
binding sites. Another well-described protein that can co-
ordinate control of divergently transcribed genes is CRP
(El-Robh and Busby, 2002). Divergent promoters that
share a central CRP binding site were shown to be inde-
pendently activated by CRP (El-Robh and Busby, 2002).
In that work CRP was acting at class II promoters, at
which the regulatory DNA site overlaps the -35 element,
for both of the divergently transcribed genes. In contrast,
ToxT presumably acts at class I promoters, at which the
regulatory DNA site is upstream of the -35 element, to
activate both acfA and acfD. Finally, ToxT itself also acti-
vates transcription of the divergent aldA and tagA promot-
ers (Parsot and Mekalanos, 1991; Parsot et al., 1991);
however, these promoters have independent control
regions and there is no overlap between the minimal ToxT-
directed aldA and tagA promoter constructs (J.H. Withey
and V.J. DiRita, in preparation). Because acfA and acfD
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both encode components of the ACF, it is logical that they
would be co-ordinately regulated, whereas aldA and tagA
encode an aldehyde dehydrogenase and a putative lipo-
protein, respectively, the co-ordinate expression of which
may be undesirable.
A previous study on the activation of acfA and acfD
transcription indicated that DNA topology is an important
factor in the regulation of these genes in V. cholerae
(Parsot and Mekalanos, 1992). The results of this previ-
ous work suggested that the acfA–acfD region carried on
a plasmid in V. cholerae did not show significant tran-
scriptional activation of either gene under inducing condi-
tions, whereas acfA–acfD constructs carried on the
bacterial chromosome did show transcriptional activation
of both genes under inducing conditions. The most likely
explanation for the difference in results between the pre-
vious work and our current work is that Parsot and
Mekalanos compared expression of their fusions in
strains grown under different environmental conditions
[37∞C, Luria–Broth (LB) at pH 8.4 as non-inducing; 30∞C,
LB at pH 6.5 as inducing], whereas we compared
expression of our fusions in strains having wild-type toxT
or a deletion of the region encoding a helix–turn–helix in
toxT (VJ740); in all of our experiments the bacteria were
grown at 30∞C in LB at pH 6.5. Similar experiments we
performed in a strain having a complete, in-frame dele-
tion of toxT had results very similar to those obtained
using VJ740 (data not shown). Because the experiments
described here are geared towards examining only the
role of ToxT in activation of acfA and acfD, we believe our
experimental system has the fewest variables, and thus
is more appropriate for pinpointing ToxT function. How-
ever, it is certainly plausible that DNA topology differs
when bacteria are grown under different environmental
conditions, and this difference in topology could affect
gene expression.
To summarize, we have identified the ToxT binding sites
located between acfA and acfD required for transcriptional
activation of both genes. Two ToxT binding sites arranged
in an inverted repeat orientation are located between acfA
and acfD and both binding sites are required for ToxT-
directed transcription of both acfA and acfD. Mutations to
one ToxT binding site do not significantly affect occupancy
of the second binding site, and the sizes of the binding
sites are consistent with one ToxT monomer binding to
each site. DNA insertions between the binding sites did
not affect occupancy by ToxT of either site, suggesting
that ToxT binds independently to the two sites. However,
these insertions did abrogate activation of transcription by
ToxT, suggesting that spacing of the binding sites relative
to the promoter is an important factor in activation. Both
ToxT monomers probably contact RNA polymerase, pre-
sumably via the a-CTDs, bound to either the acfA or acfD
promoter.
Experimental procedures
Bacterial strains and plasmids
Strains used in this study are listed in Table 1. Strains were
grown at 37∞C in LB medium for overnight cultures, and at
30∞C in LB adjusted to a starting pH of 6.5 (inducing condi-
tions) for use in b-galactosidase assays. Strains were main-
tained at -70∞C in LB + 20% glycerol. Antibiotics were used
at the following concentrations: ampicillin, 100 mg ml-1; strep-
tomycin, 100 mg ml-1. Plasmids were introduced into V. chol-
erae strains by electroporation using a Bio-Rad E. coli Pulser.
DNA manipulations
Plasmids were purified using the Qiagen Spin Miniprep or
Plasmid Midi kits. Polymerase chain reaction (PCR) was per-
formed using Taq DNA polymerase from Roche as specified
by the manufacturer. Restriction enzymes were purchased
from New England Biolabs and used as specified by the
manufacturer.
Plasmid construction
The acfA and acfD nested lacZ fusions were constructed by
PCR of the appropriate region using fresh O395 colonies as
template. PCR products were cloned between the XbaI and
HindIII sites of pTL61T (Linn and St Pierre, 1990). Site-
directed mutations were created using the splicing by overlap
extension technique (SOE) (Horton et al., 1989; 1993), after
which inserts having the desired mutations were cloned
between the XbaI and HindIII sites of pTL61T. The nucleotide
sequences of all plasmid constructs were confirmed by DNA
sequencing at the University of Michigan Sequencing Core.
b-Galactosidase assays
For b-galactosidase assays, V. cholerae strains were grown
overnight at 37∞C, subcultured at a 1:40 dilution into fresh
LB, pH 6.5, and grown for 3 h at 30∞C. Bacteria were then
placed on ice and chloramphenicol was added to 0.5 mg
ml-1. Assays were performed according to the method of
Miller (1972).
Copper-phenanthroline footprinting
EMSA was performed as previously described (Yu and
DiRita, 2002), except the DNA probe used was a PCR prod-
uct made using one 32P-end-labelled primer and one unla-
belled primer. The amount of H6-ToxT used was determined
empirically to be the amount required to shift approximately
50% of the labelled DNA. Plasmids used in the b-galactosi-
dase assays were used as PCR templates as indicated in the
text and Table 1. The PCR template used to produce the DNA
for footprinting in Fig. 7 was pJW63 (acfA1). After EMSA, the
procedure used was that of Papavassiliou (1994). Briefly, the
gel was soaked in 200 ml of 10 mM Tris-HCl, pH 8 in a glass
tray. One millilitre of 40 mM 1,10-Phenanthroline (Sigma) was
mixed with 1 ml of 9 mM CuSO4 (Sigma) for 1 min, then
diluted with 18 ml dH2O. This was added to the gel tray and
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mixed by shaking. Twenty millilitres of a 1:200 dilution of 3-
Mercaptopropionic acid (Sigma) were then added to the gel
tray and briefly mixed. The reaction continued for 7 min, and
was stopped by addition of 20 ml 28 mM Neocuproine
(Sigma), followed by shaking for 2 min. The gel was rinsed
with 1000 ml of dH2O and placed on X-ray film for 3 h. After
the film was developed, bands corresponding to free DNA
and H6-ToxT/DNA complexes were excised from the gel
based on their location in the film, and the gel slices were
crushed and the DNA was eluted overnight in 0.5 ml of 0.5
M Ammonium Acetate, pH 7.5, 1 mM EDTA, 0.1% SDS,
10 mM MgCl2. Gel pieces were pelleted by centrifugation,
and the supernatant was passed through a 0.2 mm syringe
filter and ethanol precipitated. The pellets were resuspended
in a 1:1 mixture of TE:sequencing stop solution (USB) and
radioactivity was measured with a Geiger counter. Approxi-
mately equal amounts of labelled DNA from the free DNA
and H6-ToxT/DNA complex bands were loaded on the sub-
sequent sequencing gel. The sequencing ladder was pro-
duced with a Thermo Sequenase Radiolabeled Terminator
Cycle Sequencing Kit (USB) as specified by the manufac-
turer, and the sequencing gel was prepared and run as spec-
ified by the sequencing kit manual. The same plasmid
template and the primer that was end-labelled in the EMSA/
footprinting experiment were used in the sequencing reac-
tions. Autoradiography was performed with the resulting gel,
and typical exposure times were 10–14 days.
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